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Original Article
Introduction
Liberia is a West African country with a high clinical 
and public health burden of malaria. Recent data from 
the President’s Malaria Initiative show that malaria con-
tinues to be a significant problem in Liberia, and it 
accounts for more than 40% of outpatient visits and 33% 
of inpatient deaths.1 Based on the results from the 
Liberian Malaria Indicator Surveys in 2016,2 the preva-
lence of malaria parasitemia by rapid diagnostic testing 
(RDT) in children under age 5 years was 66% in 2005, 
37% in 2009, and 45% in 2016. Malaria is most preva-
lent in the north central and southeastern parts of the 
country, where prevalence is over 60%.
Since the civil war in Liberia, little research has been 
undertaken to study the clinical presentation of malaria 
in children in Liberia. Little is also known about the 
accuracy of diagnosis and the effectiveness of antima-
laria treatment in Liberian children and whether other 
potentially life-threatening causes of febrile illness, 
which mimic malaria, may exist in this population.
It has been established in other malaria endemic 
countries that differentiating malaria from other causes 
of pediatric febrile illness can be challenging. A striking 
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Abstract
Malaria is endemic in Liberia with a prevalence rate of up to 60% in some regions, and it has been a major cause of 
death in children under 5 years of age. Prior to the recent Ebola epidemic, we undertook a prospective, hospital-
based pilot study at the National Referral Hospital in Monrovia, to characterize the presentation, accuracy of 
diagnosis, and treatment outcomes of children presenting for treatment of malaria. From June 2013 to May 2014, 
we recruited children 5 years and under who presented to the JFK Medical Center with suspected malaria. We 
collected both clinical and laboratory data on admission and on discharge. We enrolled 477 patients with an average 
age of 1.6 years. Demographic factors associated with testing negative for malaria included regular bed net use and 
prior treatment for malaria. The most common presenting symptoms of severe malaria in this population were 
headache and seizures. Of 246 patients admitted and treated for severe malaria, 33% tested negative by rapid 
diagnostic test and blood smear for malaria. The case fatality rate was higher for the patients who tested negative 
for malaria (4.9%) versus those who tested positive (0.6%). Three children who tested negative for malaria showed 
evidence of undiagnosed Salmonella typhi infection. These results suggest that malaria may be overdiagnosed and 
that the diagnoses of other infectious diseases, which present in a similar fashion, may be neglected. These findings 
underscore the need to develop rapid diagnostic tests to screen for alternative causes of febrile illness.
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example is the recent Ebola virus outbreak in West 
Africa, which posed many diagnostic and management 
challenges, since Ebola virus disease (EVD) shares 
many of the same symptoms as malaria.3 Other more 
common etiologies of febrile illness, such as Salmonella 
typhi and viral infections, are also prevalent and can also 
present in a similar fashion.4,5 Severely constrained lab-
oratory resources often make a definitive diagnosis dif-
ficult to determine by clinical findings alone, and makes 
effective treatment challenging.
We undertook a prospective, hospital-based study to 
characterize severe malaria in Liberian children age 5 
years and under. We also evaluated the accuracy of diag-
nosis and effectiveness of treatment for malaria in this 
population. Finally, we piloted a study looking at 2 
potential alternative causes of febrile illness, S typhi and 
Dengue virus, in children who were hospitalized for 
malaria but tested negative for this parasite.
Methods
Study Overview
We carried out a prospective longitudinal study of the 
clinical course for children seen for or admitted with 
suspected malaria over a 12-month period from June 
2013 through May 2014 at the JFK Medical Center, 
Monrovia, Liberia. We recruited both children being 
admitted for severe malaria and outpatients with uncom-
plicated presentations, to compare the clinical and 
demographic characteristics of each presentation. The 
study was terminated due to the Ebola epidemic, which 
reached Monrovia in late May 2014.
Study Setting
The study site, JFK Medical Center, is a tertiary care 
facility situated in Monrovia, the capital city, and is the 
National Referral Hospital for the country. The under 5 
(U5) unit consists of 30 beds with a census of about 250 
admissions per month. Children admitted to this unit are 
5 years of age and under, and approximately 42% of 
these admissions are for the treatment of malaria. The 
outpatient clinic sees approximately 1800 children per 
month, and it is estimated that 40% are seen for sus-
pected malaria.
Patient Recruitment
Inclusion criteria included the following: (1) presenta-
tion to the pediatric “U5” unit at JFK Medical Center; 
(2) signs and symptoms on admission consistent with 
severe malaria including prostration, weakness, impaired 
consciousness, seizures, respiratory distress, and treat-
ment initiated for severe malaria; (3) parental written 
consent; and (4) age range birth to 5 years of age. 
Exclusion criteria included children currently on treat-
ment for HIV or other complicated illnesses, which may 
affect immune function.
Clinical Assessment and Data Collection
A research nurse who speaks local dialects interviewed 
parents and obtained patient demographics and informa-
tion about clinical signs and symptoms of malaria. A 
standardized data collection form was utilized, which 
included the World Health Organization (WHO) criteria 
of severe malaria. Parents were also asked about any 
additional symptoms not listed on the form.
At the time of hospital discharge, or on hospital day 
3, whichever was first, the research nurse obtained addi-
tional clinical information from inpatient study subjects 
to assess treatment-related outcomes.
Clinical Laboratory Studies
In Liberia, the U5 clinical lab was utilized to perform 
malaria diagnostic laboratory studies. The First 
Response malaria rapid diagnostic test (Premier Medical 
Solutions, Inc, Denver, CO), which tests for the malaria 
HRP2 antigen, was used to diagnose patients with 
malaria. Admitted patients also had a malaria thick 
blood smear and hemoglobin level performed, as per 
standard protocol. The presence of malaria parasites was 
determined using Giemsa-stained slides and read by 
trained microscopists. For the purposes of this study, 
malaria smears were also obtained on hospital discharge 
or on hospital day 3, whichever came first, to check for 
clearance of parasites.
Clinical Management
The majority of patients were seen initially by a trained 
medical officer in the outpatient department of JFK 
Medical Center. Patients who were acutely ill and 
needed urgent medical attention were brought directly to 
the U5 unit for inpatient admission. Many of these 
patients were started presumptively on malaria treat-
ment, due to the acuity of their illness. Outpatients who 
were found to be RDT positive, but judged by the medi-
cal officer providing as not having symptoms or signs of 
severe malaria, were treated at home with oral ACT 
(artemether 20 mg/lumefantrine 120 mg), 1 pill twice 
daily for 3 days, according to a standard protocol.
Patients who were judged to have signs and symp-
toms of severe malaria (RDT positive, symptoms of 
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severe malaria by WHO criteria) were referred for inpa-
tient admission. These patients received a malaria smear 
and hemoglobin level prior to the initiation of treatment. 
Inpatients were treated using either intravenous (IV) qui-
nine (20 mg/kg loading dose, then 10 mg/kg every 8 
hours for at least 3 doses) or IV artusenate (2.4 mg/kg IV 
every 12 hours for at least 3 doses). At the time that this 
study was performed, Liberian national guidelines had 
recently changed to require IV artemisinin-based com-
pounds be used as first-line treatment for inpatient treat-
ment of severe malaria. Typically, there is no investigation 
performed to determine if patients have cleared their 
parasitemia on discharge.
After completing the specified course of IV treat-
ment, children were discharged home with an additional 
3-day course of oral ACT. We performed a repeat malaria 
blood smear on hospital discharge. Typically, there is no 
follow-up to check if patients have completely cleared 
their parasites after completing treatment.
Research Laboratory Methods
Finger prick or venous blood samples for future inves-
tigations were obtained from enrolled study partici-
pants and collected using sterile technique into BD 
anti-coagulated Microtainer tubes (˜500 µL). Blood 
samples obtained on admission for research purposes 
were centrifuged in the JFK laboratory to separate 
plasma from blood cell pellet. The samples were then 
frozen in −20°C freezer until transport. Samples were 
transferred by air carrier to UMass Medical School for 
further investigation.
Immunological Studies
Plasma samples from patients admitted with presumed 
severe malaria, but who proved to be RDT and blood 
smear negative were analyzed for the presence of other 
potential pathogens. Commercially available ELISA 
assays were used to detect IgM (immunoglobulin M) 
antibodies specific to S typhi (My BioSource, sensitivity 
95%, positive predictive value 77%) and Dengue NS1 
antigen (Corgenix, sensitivity 72%, positive predictive 
value 100%).6,7
Data Analysis
All data were transferred to a database that was created in 
REDCap. We performed descriptive statistics on all vari-
ables of interest. We explored the relationship among the 
individual covariates with malaria cases (hospitalized 
patients who were RDT positive and achieved resolution 
of symptoms and clearance of parasitemia by discharge) 
and also between cases and noncases, and patients with 
severe (patients who were RDT positive and with symp-
toms of severe malaria) versus mild disease (patients 
who were RDT positive but with no symptoms of severe 
disease). As appropriate, between group differences were 
examined using χ2 tests of independence (categorical 
variables), t tests (continuous variables), or the equiva-
lent nonparametric tests depending on the distribution of 
the variables. A 2-sided P <.05 was considered to be sta-
tistically significant.
We performed logistic regression analysis to deter-
mine the demographic and clinical characteristics that 
were most significantly associated with severe malaria 
(RDT-positive inpatients). Results were age adjusted, 
since age was noted to be a significant confounder.
Ethical Approval
Institutional review board (IRB) approval was obtained 
from the IRB at JFK Medical Center, Monrovia, 
Liberia, and from the University of Massachusetts 
Medical School, Worcester, MA (UMass IRB Docket # 
H00001063).
Results
Patient Enrollment
During the period from June 2013 to May 2014, a total of 
478 children ranging in age from 0 to 5 years who pre-
sented to JFK Medical Center in Monrovia with fever and 
suspected malaria were enrolled in this study (Figure 1). 
Sixteen patients were excluded due to missing data. Of 
the 462 remaining, 233 (50.4%) tested positive by RDT 
for malaria. Of those testing positive, 165 (70.8%) met 
the WHO criteria for severe malaria and were admitted to 
the hospital for IV treatment as previously described. The 
other 68 RDT-positive patients had uncomplicated 
malaria and were treated as outpatients with oral ACT.
Demographic and Clinical Characteristics of 
Children With Malaria
Demographic Characteristics. The average age of patients 
enrolled in the study was 1.6 years. Table 1 shows 
demographic and clinical characteristics of children 
evaluated in this study by RDT status. There were a sig-
nificantly greater proportion of patients less than 1 year 
of age in the RDT-negative group versus the RDT-posi-
tive group, 52% versus 26%, respectively. There were 
also a significantly greater proportion of patients less 
than 1 year of age who had uncomplicated versus severe 
disease, 52% versus 17%, respectively.
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Only 31% of parents reported regular bed net use; 
40% of children had a history of treatment or hospital-
ization for malaria in the past. Overall, 22% had used an 
antimalarial medication obtained from a clinic or phar-
macy prior to presentation to treat the current febrile ill-
ness. Of these, 26% were RDT-negative patients and 
19% were RDT-positive patients. Since HRP2 antigen 
and RDT positivity persists from 2 to 4 weeks after 
treatment of active infection, it is unlikely that the RDT-
negative patients, who typically presented with fever for 
less than 4 days, were cases of malaria.
Children who tested RDT positive were older and 
were more likely to be from an urban environment ver-
sus those who were RDT negative. This is likely due to 
the fact that access to hospital care is very challenging in 
rural environments. Children who tested negative for 
malaria were more likely to be sleeping under bed nets 
regularly as compared with their RDT-positive counter-
parts (Table 1 and Figure 2).
Demographic characteristics associated with severe 
malaria (WHO criteria, inpatient admission) versus 
those associated with uncomplicated malaria (outpatient 
treatment) are shown in Table 2 and Figure 2. Patients 
from urban areas were more likely to present with severe 
malaria. Alternatively, patients with uncomplicated dis-
ease were more likely to have been using bed nets regu-
larly, used an antimalarial medication prior to 
presentation, and were more likely to have been treated 
for malaria in the past when compared with those who 
presented with severe disease.
Clinical Characteristics. Clinical signs and symptoms 
were elicited from all study participants and are shown 
in Table 1. The clinical symptoms most significantly 
associated with a diagnosis of malaria were headache 
and vomiting (Figure 2). Vomiting was not a symptom 
on the original checklist; rather it was a symptom that 
was added when patients were asked about “other symp-
toms.” It was found to be significantly associated with 
testing RDT positive in this population. The only clini-
cal symptom significantly associated with being RDT 
negative was diarrhea.
Clinical data were also analyzed to determine if there 
were clinical symptoms that were associated with severe 
malaria (RDT-positive inpatients) versus uncomplicated 
disease (RDT-positive outpatients; Table 2). Headache, 
prostration, weakness, and seizures were significantly 
associated with severe disease. The symptoms most sig-
nificantly associated with uncomplicated disease 
included diarrhea and cough (Figure 2).
Treatment Outcomes
A total of 246 patients were admitted to the hospital with 
febrile illness and malaria and were presumptively 
treated for malaria. These patients were assessed on 
admission and followed through discharge or hospital 
day 3 to determine their outcomes (Figure 3).
Among these 246 patients admitted and treated pre-
sumptively for malaria, 165 (67%) tested positive for 
malaria by RDT. The remaining 81 patients tested nega-
tive by RDT and malaria smear. There were 5 deaths in 
this young patient cohort, including 1 in the malaria-
positive group and 4 in the malaria-negative group. The 
hospital case fatality rate for patients with RDT-positive 
malaria was 0.6%; the case fatality rate for those who 
tested RDT negative, but who were still treated for 
malaria, was 4.9%. Due to the lack of diagnostic capac-
ity, the causes of death were not well defined.
Of the 165 patients who were admitted and tested 
positive for malaria, 142 (86%) responded effectively to 
treatment (resolved symptoms, parasite cleared on day 3 
smear). However, 19 patients (11%) admitted with RDT-
positive malaria did not clear their parasites after treat-
ment and harbored parasite levels ranging from 1+ to 
4+. Nevertheless, the patients in this group had resolved 
478 patients 
enrolled June 
2013-May 2014
462 patients 
analyzed
246 Inpatient
165 RDT+ 
(Severe Malaria)
81 RDT -
216 Outpatients
68 
RDT+(Uncomp. 
malaria)
148 RDT -
16 patients 
missing data 
(5%)
Figure 1. Patients recruited to study. A total of 478 
patients presented to the hospital with fever and signs and 
symptoms consistent with malaria and were enrolled in the 
study. Patients with missing data were excluded. Of the 462 
patients with data, 246 had suspected severe malaria, and 
were admitted. A total of 216 had milder disease, and were 
evaluated as outpatients. Eighty-one of the 246 patients 
admitted with a diagnosis of severe malaria tested negative 
for malaria. Of the 216 outpatients with symptoms of 
malaria, only 68 tested positive for malaria.
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their acute symptoms by day 3 and were discharged 
home, with malaria-positive blood smears (parasitemia is 
not routinely retested after symptoms resolve). The aver-
age age of this cohort was 28 months, and only 2 were 
less than 9 months old. The majority of these patients 
were treated with IV artusenate as a monotherapy.
Patients who were hospitalized, but were RDT nega-
tive, were screened retrospectively for 2 alternative 
causes of febrile illness: Dengue virus and S typhi. A total 
of 3 patients (3.7%) who were RDT negative tested posi-
tive for S typhi IgM by ELISA. All of these children, who 
were older than 3 years, were treated with antimalarials, 
but none received antibiotics because this test was done 
retrospectively as part of this pilot research project. Of 
the 3 patients, 2 resolved symptoms and were discharged 
on day 3. Since the patient’s symptoms resolved without 
antibiotic treatment, it is possible that this represented a 
false positive test result. The third patient did not resolve 
symptoms immediately and was hospitalized for 7 days. 
The hospitalized RDT-negative patients were also tested 
retrospectively for Dengue virus by ELISA to NS1 anti-
gen, but none tested positive.
Discussion
We undertook this pilot study prior to the Ebola epi-
demic to learn about how severe malaria presents in 
Liberia and whether we could identify additional risk 
factors associated with severe disease in young children 
5 years and under. We also sought to determine the out-
comes of children admitted to the hospital with a diag-
nosis of severe malaria. Finally, we were interested in 
learning if patients who were being admitted and treated 
for severe malaria could be suffering from an undiag-
nosed, alternative type of febrile illness. To our knowl-
edge, there have been no prior studies that describe the 
presenting features and clinical outcomes of severe 
malaria in Liberian children.
Clinical and Demographic Features of Severe 
Malaria in Liberian Children
In resource-limited settings such as Liberia, it is pre-
sumed that the majority of patients do not seek hospital 
care due to distance, lack of transportation, and expense. 
Studies performed in other countries with high malaria 
burdens have been helpful in understanding health care 
seeking behaviors of parents with children experiencing 
symptoms of malaria, and how these behaviors differ in 
rural versus urban environments.8-10 Replicating these 
studies in Liberia will be an important next step in to 
moving forward with malaria control programs. Also, in 
these remote regions, there are few diagnostic resources 
available to help distinguish malaria from a myriad of 
Table 1. Demographic and Clinical Characteristics of Children With Severe Malaria.
Characteristics RDT Positive (n = 232) RDT Negative (n = 230) P
Demographic characteristics
 Age in months (mean) 25.0 14.0 <.001
 n % n %  
 Sex (female) 107 46.1 105 45.7 .93
 Regular bed net use 50 21.6 82 35.7 <.001
 Treated for malaria in past 92 40.0 93 40.4 .92
WHO-defined symptoms of severe malaria
 Febrile days (mean) 3.75 3.66 .68
 Impaired consciousness 19 8.2 10 4.30 .12
 Jaundice 2 0.01 2 0.01 1.00
 Prostration/weakness 149 64.2 98 42.6 <.001
 Respiratory distress 38 16.4 17 7.39 .013
 Seizures 57 24.5 26 11.3 .002
 Severe anemia (Hgb < 5.0 mg/dL) 9 7.09 0 0.00  
 Hyperparasitemia 69 0 0.00  
Other symptoms reported
 Cough 142 61.2 128 55.7 .26
 Diarrhea 50 22.3 51 22.2 .91
 Headache 179 77.0 117 50.9 <.001
 Vomiting 90 38.8 47 20.4 <.001
Abbreviations: RDT, rapid diagnostic testing; WHO, World Health Organization; Hgb, hemoglobin.
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other febrile illnesses. Distinguishing children at risk for 
severe malaria can be useful in identifying those chil-
dren who need prompt referral for hospital management. 
The use of RDTs in these remote regions has been 
extremely helpful for this reason.
We identified several demographic factors that help 
distinguish children who are at risk for severe disease. 
Consistent with studies from other malaria endemic 
countries, we found that young age is a significant risk 
factor in this population of children who are exposed to 
a constant, high level of malaria transmission. In our 
population, the mean age of all children who tested RDT 
positive for malaria was 2.1 years. The mean age of chil-
dren with severe malaria, requiring hospitalization, was 
slightly higher (2.4 years).
Very young children, from age 0 to 12 months, were 
less likely to test positive for malaria even when symp-
tomatic. This likely reflects the presence of maternal 
IgG antibodies in this age group. Maternal antimalaria 
immunoglobulin confers protection from malaria and is 
thought to persist from birth up to 6 to 9 months of age.11 
In contrast, slightly older children (1-4 years) were more 
likely to have severe malaria. Since maternal antibody is 
waning at this point, children in this age group have lit-
tle immunity and are constantly exposed to infective 
mosquitoes.
These results are consistent with prior epidemiologic 
studies of severe malaria in other countries with high 
transmission, such as Tanzania and Kenya, which have 
shown that the median age of children affected is inversely 
proportional to transmission intensity.12 In areas of intense 
malaria transmission such as Liberia, younger children 
with undeveloped immunity are more likely to be affected 
and hospitalized, as was seen in our study.
In comparing patients with severe versus uncompli-
cated malaria, we found that a higher percentage of 
patients with uncomplicated presentations had reported 
prior episodes of malaria. This suggests that children 
Figure 2. Logistic regression analysis of demographic and clinical features associated with rapid diagnostic testing (RDT)-
positive patients versus RDT-negative (top panel) and with RDT-positive outpatients (uncomplicated malaria) versus RDT-
positive inpatients (severe malaria; bottom panels).
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Table 2. Demographic and Clinical Characteristics of Patients With Severe (Inpatient) Versus Uncomplicated (Outpatient) 
Malaria.
Characteristics RDT + Inpatients (n = 165) RDT + Outpatients (n = 68) P
Age (mean, years) 2.41 1.37 <.001
 n % n %  
Female 68 41.2 39 57.3 <.001
Urban 104 63.0 34 50.0 <.001
Regular bed net use 20 12.1 30 44.1 <.001
Treated for malaria in the past 48 29.0 45 66.1 <.001
Antimalarial use prior to presentation 8 6.99 30 44.8 <.001
Headache 156 94.0 24 35.3 <.001
Prostration/weakness 133 80.1 16 23.5 <.001
Impaired consciousness 18 10.8 1 0.00 .016
Pallor 0 0.00 0 0.00 1.00
Seizure 54 32.5 3 2.94 <.001
Cough 107 64.5 35 48.5 .08
Diarrhea 37 22.3 13 17.6 .73
Jaundice 1 0.01 0 0.00 1.000
Respiratory distress 36 21.7 0 0.01 <.001
Vomiting 81 48.8 9 13.2 <.001
Febrile days (mean) 3.70 3.81 .67
Abbreviation: RDT, rapid diagnostic testing.
Figure 3. Results of febrile case investigations for admitted patients. Of the 246 patients who were admitted with severe 
malaria, 165 tested positive for malaria by rapid diagnostic testing (RDT) and malaria blood smear. Patients who tested positive 
for malaria were then screened for malaria on discharge. Of the admitted patients, 81 tested negative by smear and/or RDT. 
These patients were tested for Salmonella typhii and Dengue virus as alternative causes of their fever.
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with reported past infections had an opportunity to 
develop semiprotective antimalarial immunity that 
would result in uncomplicated infections compared with 
those with no reported past infections. This finding is 
consistent with other reports in the literature.13
We identified several clinical symptoms that are 
associated with severe malaria in Liberian children, and 
which may help identify high-risk patients. In particular, 
prostration, weakness, seizures, and respiratory distress 
were significantly associated with being hospitalized 
and RDT positive. A large number of children in our 
population also presented with symptoms of headache 
and vomiting, which were highly associated with severe 
disease. These findings align with the WHO criteria for 
severe malaria, which have been described previ-
ously.14,15 Our findings are consistent with these obser-
vations and provide reassurance that clinical signs and 
symptoms of malaria are informative in this setting. In 
addition, in this setting, headache and vomiting may 
also be important clinical indicators of malaria. These 
symptoms have frequently been described in popula-
tions presenting with malaria, although are not listed as 
WHO criteria.16,17
Treatment Outcomes
Many public health efforts designed to address the man-
agement of malaria in Africa have focused on bringing 
patients with febrile illness to hospital attention, but few 
studies have examined the accuracy of diagnosis and 
appropriateness of hospital treatment. Current protocols 
in use to diagnose severe malaria are based on reducing 
the risk of mortality and are sensitive, but not specific.18 
Yet the presumptive diagnosis of malaria, and the conse-
quent neglect of alternative diagnoses in hospitalized 
patients have been demonstrated to affect morbidity and 
mortality. Therefore, second motivation for this pilot 
study was to evaluate the accuracy of diagnosis and 
treatment outcomes for children admitted with and 
treated for severe malaria in the hospital setting.
With regard to accuracy of diagnosis, 67% of 
patients admitted with a diagnosis of severe malaria 
were accurately diagnosed. However, approximately 
one third of the children in our study who were admit-
ted and treated for severe malaria were RDT negative 
and malaria smear negative on admission. Consequently, 
we noted a 4-fold increase in case fatality rates in the 
RDT negative patients when compared with the RDT 
positive patients. This suggests that their deaths were 
caused by an alternative, undiagnosed, and therefore 
untreated illness.
To test this hypothesis, we screened the 81 RDT neg-
ative hospitalized patients for 2 potential pathogens, 
which share clinical features with malaria: S typhi, a 
pathogen known to be endemic in this population,4 and 
Dengue virus, a pathogen which has been reported in the 
West African region.19 S typhi presents in a similar fash-
ion as malaria, with high fever and vomiting. If left 
untreated, it can lead to intestinal perforation and death. 
There were 3 children who tested positive for this patho-
gen, making it the likely cause of their illness. This sup-
ports our finding that children who are presumed to have 
malaria are at high risk of being undiagnosed and the 
true cause of their illness left untreated. Our pilot study 
screened for only 2 alternative causes of illnesses. Prior 
studies have also demonstrated that overdiagnosis of 
malaria, and the resulting neglect of other diagnoses, 
results in higher fatality rates for the patients who do not 
have malaria. A prospective hospital-based study per-
formed in 10 hospitals in Tanzania concluded that 
patients admitted with a diagnosis of malaria who were 
slide negative were often not treated with antibiotics and 
had twice the hospital case-fatality rate of their slide 
positive counterparts.20
Future studies designed to elucidate the causes of 
acute febrile illness will be important if undertaken in 
West Africa, since it is likely that EVD may be endemic 
in this area.
With regard to treatment outcomes, the majority of the 
165 admitted, RDT-positive patients (87%) responded to 
antimalarial treatment with IV quinine or artusenate, 
resolved their symptoms, and were discharged home by 
hospital day 3. However, 11.5% of patients with malaria 
were noted to have persistent parasitemia on their day 3 
blood smear and had not cleared their parasites at the time 
of discharge. Patients are not usually checked for persis-
tence of parasitemia on discharge, so this was a new find-
ing. The treatment protocol includes an additional 3-day 
course of artemisinin-based combination therapy (ACT) 
given to patients to complete postdischarge, so it is pos-
sible that these patients did eventually clear their para-
sites. There is no follow-up data to support this; however, 
as patients do not typically follow up for repeat blood 
smear after their treatment is completed.
This group of patients who did not clear their parasit-
emia will be an important group to follow in future stud-
ies for many reasons. It is well known that malaria 
treatment does not always induce sterilizing immunity, 
and even though a child may no longer suffer the symp-
toms of malaria or be at risk of death, they can still har-
bor parasites. These children who carry malaria 
asymptomatically also serve as a reservoir to infect oth-
ers. Therefore, determining if they have cleared their 
infection is of great importance. Furthermore, those chil-
dren who continue to harbor parasites after treatment is 
complete could be doing so because they are developing 
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tolerance to malaria parasites. The mechanisms involved 
in the development of this tolerance are important in 
understanding how immunity to malaria develops. This 
correlate of protection could be useful in strategies used 
in malaria vaccine development. Finally, it is possible 
that these patients may have not cleared parasites because 
of antimalarial drug resistance, as has been described by 
the WHO.21 Polymorphisms in 2 drug resistance genes, 
pfcrt and pfmdr1, have recently been described in 
Liberia.22 Surveillance methods should continue to 
screen such patients for parasites harboring drug resis-
tance mutations.
Strengths of this study include the fact that, to our 
knowledge, this is the first study investigating the demo-
graphic and clinical characteristics of malaria in Liberian 
children since the second civil war, which began in 
1999. Our data are also novel in that they were collected 
prior to the EVD epidemic and may be helpful in estab-
lishing baseline characteristics of this population.
Our pilot study had several limitations that need to 
be kept in mind in interpreting the study results. We 
worked with a relatively small sample of patients who 
were referred to, and treated at, the national referral 
hospital. This population of patients may not be repre-
sentative of the Liberian population as a whole, so we 
do not know if our results are generalizable. Our lim-
ited budget prevented full exploration of WHO signs 
and symptoms of malaria, such as hyperglycemia, aci-
dosis, and hyperparasitemia. These laboratory investi-
gations are not routinely performed on patients at JFK 
Medical Center; therefore, we were not able to validate 
symptoms with clinical diagnostics. We were also 
unable to screen for other types of pathogens known to 
be prevalent in African children, such as non-typhoid 
Salmonella and Streptococcus pneumococcus. Finally, 
we were unable to follow patients after hospital dis-
charge, to learn if they later cleared their parasites after 
discharge.
Our pilot study is a first step in characterizing the 
presentation and treatment of malaria in young children 
and defining the landscape of acute febrile illness in 
Liberia. Further investigations are needed to better 
define the myriad causes of febrile illnesses in this set-
ting, as has been accomplished in other countries.23 This 
knowledge will help make decisions about resource 
allocation and to determine which additional diagnostic 
testing will need to be implemented. The recent EVD 
epidemic underscores the crucial need for this informa-
tion. It is postulated that if an RDT for EVD existed at 
the time of the outbreak, the number of deaths caused by 
this outbreak would have been up to one third fewer.24 A 
better approach to malaria, and a better understanding of 
alternative causes of acute febrile illness that exist in 
this region will help develop relevant point of care 
diagnostics and broader treatment algorithms and will 
ultimately translate into improved outcomes for young 
children.
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